Michael Bitzer

Bitzer with the [[Schwenninger Wild Wings]] in 2024 Michael Bitzer is a German-American ice hockey goaltender currently playing for the Schwenninger Wild Wings of the Deutsche Eishockey Liga. He was an All-American for Bemidji State. Provided by Wikipedia
Showing 1 - 20 results of 21 for search 'Michael Bitzer', query time: 0.07s Refine Results
  1. 1
    Fully automated whole-liver volume quantification on CT-image data: Comparison with manual volumetry using enhanced and unenhanced images as well as two different radiation dose levels and two reconstruction kernels

    Fully automated whole-liver volume quantification on CT-image data: Comparison with manual volumetry using enhanced and unenhanced images as well as two different radiation dose le... by Florian Hagen, Antonia Mair, Michael Bitzer, Hans Bösmüller, Marius Horger

    Published 2021-01-01
    Get full text
    Article
  2. 2
    Fully automated whole-liver volume quantification on CT-image data: Comparison with manual volumetry using enhanced and unenhanced images as well as two different radiation dose levels and two reconstruction kernels.

    Fully automated whole-liver volume quantification on CT-image data: Comparison with manual volumetry using enhanced and unenhanced images as well as two different radiation dose le... by Florian Hagen, Antonia Mair, Michael Bitzer, Hans Bösmüller, Marius Horger

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients

    Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients by Georgy Berezhnoy, Rosi Bissinger, Anna Liu, Claire Cannet, Hartmut Schäfer, Katharina Kienzle, Michael Bitzer, Michael Bitzer, Helene Häberle, Siri Göpel, Christoph Trautwein, Yogesh Singh, Yogesh Singh, Yogesh Singh

    Published 2023-05-01
    Get full text
    Article
  4. 4
    FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

    FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellu... by Christopher Hackenbruch, Christopher Hackenbruch, Christopher Hackenbruch, Jens Bauer, Jens Bauer, Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Yacine Maringer, Yacine Maringer, Annika Nelde, Annika Nelde, Monika Denk, Monika Denk, Lisa Zieschang, Lisa Zieschang, Christine Kammer, Christine Kammer, Birgit Federmann, Birgit Federmann, Birgit Federmann, Susanne Jung, Susanne Jung, Susanne Jung, Peter Martus, Nisar P. Malek, Nisar P. Malek, Nisar P. Malek, Nisar P. Malek, Nisar P. Malek, Konstantin Nikolaou, Konstantin Nikolaou, Konstantin Nikolaou, Helmut R. Salih, Helmut R. Salih, Michael Bitzer, Michael Bitzer, Michael Bitzer, Michael Bitzer, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz

    Published 2024-03-01
    Get full text
    Article
  5. 5
    COVID-19 in persons aged 70+ in an early affected German district: Risk factors, mortality and post-COVID care needs-A retrospective observational study of hospitalized and non-hospitalized patients.

    COVID-19 in persons aged 70+ in an early affected German district: Risk factors, mortality and post-COVID care needs-A retrospective observational study of hospitalized and non-hos... by Matthias L Herrmann, Johannes-Martin Hahn, Birgit Walter-Frank, Desiree M Bollinger, Kristina Schmauder, Günter Schnauder, Michael Bitzer, Nisar P Malek, Gerhard W Eschweiler, Siri Göpel

    Published 2021-01-01
    Get full text
    Article
  6. 6
    Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells.

    Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells. by Sascha Venturelli, Alexander Berger, Alexander Böcker, Christian Busch, Timo Weiland, Seema Noor, Christian Leischner, Sabine Schleicher, Mascha Mayer, Thomas S Weiss, Stephan C Bischoff, Ulrich M Lauer, Michael Bitzer

    Published 2013-01-01
    Get full text
    Article
  7. 7
    Selective protection of human liver tissue in TNF-targeting of cancers of the liver by transient depletion of adenosine triphosphate.

    Selective protection of human liver tissue in TNF-targeting of cancers of the liver by transient depletion of adenosine triphosphate. by Timo Weiland, Kathrin Klein, Martina Zimmermann, Tobias Speicher, Sascha Venturelli, Alexander Berger, Heike Bantel, Alfred Königsrainer, Martin Schenk, Thomas S Weiss, Albrecht Wendel, Matthias Schwab, Michael Bitzer, Ulrich M Lauer

    Published 2012-01-01
    Get full text
    Article
  8. 8
    External Validation of COVID-19 Risk Scores during Three Waves of Pandemic in a German Cohort—A Retrospective Study

    External Validation of COVID-19 Risk Scores during Three Waves of Pandemic in a German Cohort—A Retrospective Study by Lukas Häger, Philipp Wendland, Stephanie Biergans, Simone Lederer, Marius de Arruda Botelho Herr, Christian Erhardt, Kristina Schmauder, Maik Kschischo, Nisar Peter Malek, Stefanie Bunk, Michael Bitzer, Beryl Primrose Gladstone, Siri Göpel

    Published 2022-10-01
    Get full text
    Article
  9. 9
    Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity

    Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity by Annika Nelde, Jonas Rieth, Malte Roerden, Marissa L. Dubbelaar, Naomi Hoenisch Gravel, Jens Bauer, Reinhild Klein, Tobias Hoheisel, Hartmut Mahrhofer, Siri Göpel, Michael Bitzer, Sebastian Hörber, Andreas Peter, Jonas S. Heitmann, Juliane S. Walz

    Published 2022-12-01
    Get full text
    Article
  10. 10
    Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.

    Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68. by Ivaylo Gentschev, Meike Müller, Marion Adelfinger, Stephanie Weibel, Friedrich Grummt, Martina Zimmermann, Michael Bitzer, Martin Heisig, Qian Zhang, Yong A Yu, Nanhai G Chen, Jochen Stritzker, Ulrich M Lauer, Aladar A Szalay

    Published 2011-01-01
    Get full text
    Article
  11. 11
    A data management infrastructure for the integration of imaging and omics data in life sciences

    A data management infrastructure for the integration of imaging and omics data in life sciences by Luis Kuhn Cuellar, Andreas Friedrich, Gisela Gabernet, Luis de la Garza, Sven Fillinger, Adrian Seyboldt, Tobias Koch, Sven zur Oven-Krockhaus, Friederike Wanke, Sandra Richter, Wolfgang M. Thaiss, Marius Horger, Nisar Malek, Klaus Harter, Michael Bitzer, Sven Nahnsen

    Published 2022-02-01
    Get full text
    Article
  12. 12
    Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma

    Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma by Stephan Spahn, Daniel Roessler, Radu Pompilia, Gisela Gabernet, Beryl Primrose Gladstone, Marius Horger, Saskia Biskup, Magdalena Feldhahn, Sven Nahnsen, Franz J. Hilke, Bernhard Scheiner, Jean-François Dufour, Enrico N. De Toni, Matthias Pinter, Nisar P. Malek, Michael Bitzer

    Published 2020-12-01
    Get full text
    Article
  13. 13
    Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases

    Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases by Laura Uder, Marcel Nachbar, Sarah Butzer, Jessica Boldt, Sabrina Baumeister, Michael Bitzer, Alfred Königsrainer, Thomas Seufferlein, Rüdiger Hoffmann, Sergios Gatidis, Konstantin Nikolaou, Daniel Zips, Daniel Zips, Daniel Zips, Daniela Thorwarth, Daniela Thorwarth, Cihan Gani, Cihan Gani, Simon Boeke, Simon Boeke

    Published 2023-01-01
    Get full text
    Article
  14. 14
    The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma

    The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma by Stephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko, Aaron Stahl, Yvonne Rasen, Christine Geisler, Kristina Ruhm, Marion Klaumuenzer, Thales Kronenberger, Stefan A. Laufer, Holly Sundberg-Malek, Khac Cuong Bui, Marius Horger, Saskia Biskup, Klaus Schulze-Osthoff, Markus Templin, Nisar P. Malek, Antti Poso, Michael Bitzer

    Published 2024-02-01
    Get full text
    Article
  15. 15
    Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial

    Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial by Maria Pouyiourou, Bianca N. Kraft, Timothy Wohlfromm, Michael Stahl, Boris Kubuschok, Harald Löffler, Ulrich T. Hacker, Gerdt Hübner, Lena Weiss, Michael Bitzer, Thomas Ernst, Philipp Schütt, Thomas Hielscher, Stefan Delorme, Martina Kirchner, Daniel Kazdal, Markus Ball, Klaus Kluck, Albrecht Stenzinger, Tilmann Bochtler, Alwin Krämer

    Published 2023-10-01
    Get full text
    Article
  16. 16
    COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants

    COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants by Daniel Junker, Alex Dulovic, Matthias Becker, Teresa R. Wagner, Philipp D. Kaiser, Bjoern Traenkle, Katharina Kienzle, Stefanie Bunk, Carlotta Struemper, Helene Haeberle, Kristina Schmauder, Natalia Ruetalo, Nisar Malek, Karina Althaus, Michael Koeppen, Ulrich Rothbauer, Juliane S. Walz, Michael Schindler, Michael Bitzer, Siri Göpel, Nicole Schneiderhan-Marra

    Published 2022-05-01
    Get full text
    Article
  17. 17
    Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma

    Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma by Michael Bitzer, Stephan Spahn, Sepideh Babaei, Marius Horger, Stephan Singer, Klaus Schulze-Osthoff, Pavlos Missios, Sergios Gatidis, Dominik Nann, Sven Mattern, Veit Scheble, Konstantin Nikolaou, Sorin Armeanu-Ebinger, Martin Schulze, Christopher Schroeder, Saskia Biskup, Janina Beha, Manfred Claassen, Kristina Ruhm, Antti Poso, Nisar P. Malek

    Published 2021-09-01
    Get full text
    Article
  18. 18
    Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3)

    Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal can... by Susanne Jung, Susanne Jung, Susanne Jung, Richard F. Schlenk, Richard F. Schlenk, Christopher Hackenbruch, Christopher Hackenbruch, Christopher Hackenbruch, Sandra S.L. Roldan Pinzon, Michael Bitzer, Martin Pflügler, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Gundram Jung, Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Helmut R. Salih, Helmut R. Salih

    Published 2024-02-01
    Get full text
    Article
  19. 19
    Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults

    Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults by Claudia Tandler, Jonas S. Heitmann, Tanja M. Michel, Maddalena Marconato, Simon U. Jaeger, Christian M. Tegeler, Monika Denk, Marion Richter, Melek Tutku Oezbek, Yacine Maringer, Sarah M. Schroeder, Nicole Schneiderhan-Marra, Karl-Heinz Wiesmüller, Michael Bitzer, Natalia Ruetalo, Michael Schindler, Christoph Meisner, Imma Fischer, Hans-Georg Rammensee, Helmut R. Salih, Juliane S. Walz

    Published 2024-02-01
    Get full text
    Article
  20. 20
    The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

    The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma by Jens Bauer, Natalie Köhler, Yacine Maringer, Philip Bucher, Tatjana Bilich, Melissa Zwick, Severin Dicks, Annika Nelde, Marissa Dubbelaar, Jonas Scheid, Marcel Wacker, Jonas S. Heitmann, Sarah Schroeder, Jonas Rieth, Monika Denk, Marion Richter, Reinhild Klein, Irina Bonzheim, Julia Luibrand, Ursula Holzer, Martin Ebinger, Ines B. Brecht, Michael Bitzer, Melanie Boerries, Judith Feucht, Helmut R. Salih, Hans-Georg Rammensee, Stephan Hailfinger, Juliane S. Walz

    Published 2022-10-01
    Get full text
    Article

Search Tools: